SG11202101889PA - Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells - Google Patents

Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells

Info

Publication number
SG11202101889PA
SG11202101889PA SG11202101889PA SG11202101889PA SG11202101889PA SG 11202101889P A SG11202101889P A SG 11202101889PA SG 11202101889P A SG11202101889P A SG 11202101889PA SG 11202101889P A SG11202101889P A SG 11202101889PA SG 11202101889P A SG11202101889P A SG 11202101889PA
Authority
SG
Singapore
Prior art keywords
cells
vaccines
infective drugs
evaluating anti
induced
Prior art date
Application number
SG11202101889PA
Other languages
English (en)
Inventor
Kazuo Miyazaki
Atsushi Yamanaka
Minoru Okada
Satoru SENJYU
Original Assignee
Mican Tech Inc
Univ Kumamoto
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mican Tech Inc, Univ Kumamoto, Univ Osaka filed Critical Mican Tech Inc
Publication of SG11202101889PA publication Critical patent/SG11202101889PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161—Methods of inactivation or attenuation
    • C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202101889PA 2018-08-27 2019-08-26 Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells SG11202101889PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018158512 2018-08-27
PCT/JP2019/033378 WO2020045368A1 (ja) 2018-08-27 2019-08-26 不死化単球細胞および誘導細胞を用いた抗感染症薬，ワクチンなどの評価方法

Publications (1)

Publication Number Publication Date
SG11202101889PA true SG11202101889PA (en) 2021-03-30

Family

ID=69644366

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101889PA SG11202101889PA (en) 2018-08-27 2019-08-26 Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells

Country Status (6)

Country Link
US (1) US20210277361A1 (zh)
EP (1) EP3845639A4 (zh)
JP (1) JP7376013B2 (zh)
CN (1) CN112601815A (zh)
SG (1) SG11202101889PA (zh)
WO (1) WO2020045368A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021100828A1 (zh) * 2019-11-19 2021-05-27
EP4151723A1 (en) * 2020-05-13 2023-03-22 Agc Inc. Method for producing human professional antigen-presenting cells
WO2022075384A1 (ja) * 2020-10-07 2022-04-14 マイキャン・テクノロジーズ株式会社 コロナウイルス感染性細胞及びその調製方法
CN113345600B (zh) * 2021-05-06 2024-02-27 中国食品药品检定研究院 一种抗感染药物注射剂的有效性评价方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ503522A (en) * 1997-08-28 2001-06-29 Us Army Attenuated Japanese encephalitis virus adapted to vero cell and a Japanese encephalitis vaccine
JP2001046061A (ja) * 1999-08-04 2001-02-20 Handai Biseibutsubiyou Kenkyukai 弱毒デングウイルス及びこれを用いるデング熱ワクチン
EP1351969A4 (en) * 2000-12-13 2006-04-05 Immunex Corp PROCESS RELATING TO THE PRODUCTION OF IMMORTAL DENDRITIC CELL LINES
CN1408850A (zh) * 2001-09-18 2003-04-09 王虹 人血树突状细胞永生化技术
FR2848565B1 (fr) * 2002-12-16 2007-04-06 Ets Francais Du Sang Lignee de cellules dendritiques gen2.2
WO2008056734A1 (fr) 2006-11-08 2008-05-15 National University Corporation Kumamoto University Procédé de production de cellules dendritiques à partir de cellules souches d'embryons humains
PE20110992A1 (es) * 2009-02-17 2012-02-12 Glaxosmithkline Biolog Sa Composicion inmunogenica que comprende un antigeno del virus del dengue
JP5306943B2 (ja) 2009-08-24 2013-10-02 全国農業協同組合連合会 弱毒ウイルスの作出方法
US10034900B2 (en) * 2010-09-30 2018-07-31 National University Corporation Kumamoto University Method of producing myeloid blood cells
RU2683544C1 (ru) * 2013-12-12 2019-03-28 Интервет Интернэшнл Б.В. Иммортализованный макрофаг
JP6903866B2 (ja) 2016-01-27 2021-07-14 国立大学法人 熊本大学 血液由来単球の増殖誘導方法

Also Published As

Publication number Publication date
US20210277361A1 (en) 2021-09-09
JPWO2020045368A1 (ja) 2021-08-10
WO2020045368A1 (ja) 2020-03-05
CN112601815A (zh) 2021-04-02
EP3845639A4 (en) 2022-05-11
JP7376013B2 (ja) 2023-11-08
EP3845639A1 (en) 2021-07-07

Similar Documents

Publication Publication Date Title
SG11202101889PA (en) Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells
EP3146744B8 (en) Method, apparatus, and system for providing a security check
EP3351172A4 (en) EAR FORM ANALYSIS METHOD, EAR FORM ANALYSIS DEVICE, AND EAR FORM MODEL GENERATION METHOD
DK3328467T3 (da) Sensor, patron og lægemiddeladministrationsanordning
EP3242627A4 (en) System, device, and method for improved intraoral scanning accuracy
EP3618347A4 (en) METHOD AND DEVICE FOR ENTERING A CHECK CODE
PL3241645T3 (pl) Urządzenie, system modułowy i sposób wprowadzania elastycznego pierścienia do wewnętrznego rowka
IL283343B (en) Systems, devices and methods for assembling them, in order to provide material
EP3172722A4 (en) Method and system for fare collection and validation on a transportation network
EP3357476A4 (en) Drug inspection device and method, and program
EP3455759A4 (en) NEURONAL NETWORK ARCHITECTURES FOR THE EVALUATION AND VISUALIZATION OF VARIATIONS OF BIOLOGICAL SEQUENCES USING A MOLECULAR PHENOTYPE AND SYSTEMS AND METHODS THEREFOR
PT3364601T (pt) Método, dispositivo e sistema de testes
GB2538506B (en) A device, system and method for vibration sensitivity assessment
EP3669780C0 (en) METHOD, APPARATUS AND SYSTEM FOR A COMPENSATED HEARING TEST
MX2017015201A (es) Metodo y aparato para construir una torre de hormigon.
EP3362791C0 (fr) Systeme de certification d'un depistage d'une substance gazeuse exhalee par un individu, et procede mettant en oeuvre le systeme
GB2565493B (en) Method for time drift measurement, seismic node and seismic node handling system
EP3208329A4 (en) Method for producing gamma-delta t cells, and pharmaceutical
HK1257659A1 (zh) 收費系統、位置測量方法和程序
IL260062B (en) Method, device and system for the treatment, sorting and vaccination of live poultry
EP3600672A4 (en) SYSTEM, FLUID CARTRIDGE AND METHODS OF USING ACTUATED SURFACE-ATTACHED RODS FOR CELL TREATMENT
RS63278B1 (sr) Uređaj za detektovanje obrušavanja vrata, sistem za detektovanje obrušavanja vrata, kao i postupak detektovanja obrušavanja vrata
GB2574644B (en) A location system, method, and calibration method
EP3592145C0 (fr) Système et procédé de vitrification d'une substance biologique
EP3459444A4 (en) BIOLOGICAL INFORMATION MEASURING DEVICE, BIOLOGICAL INFORMATION MEASURING DEVICE, BIOLOGICAL INFORMATION MEASURING METHOD, AND BIOLOGICAL INFORMATION MEASURING PROGRAM